Abstract: An integrated circuit (IC) device comprises a substrate comprising a glass core. The glass core comprises a first surface and a second surface opposite the first surface, and a first sidewall between the first surface and the second surface. The glass core may include a conductor within a through-glass via extending from the first surface to the second surface and a build-up layer. The glass cord comprises a plurality of first areas of the glass core and a plurality of laser-treated areas on the first sidewall. A first one of the plurality of laser-treated areas may be spaced away from a second one of the plurality of laser-treated areas. A first area may comprise a first nanoporosity and a laser-treated area may comprise a second nanoporosity, wherein the second nanoporosity is greater than the first nanoporosity.

Abstract: A die assembly is disclosed. The die assembly includes a die, one or more die pads on a first surface of the die and a die attach film on the die where the die attach film includes one or more openings that expose the one or more die pads and that extend to one or more edges of the die.

Abstract: A die assembly is disclosed. The die assembly includes a die, one or more die pads on a first surface of the die and a die attach film on the die where the die attach film includes one or more openings that expose the one or more die pads and that extend to one or more edges of the die.

Abstract: Embodiments of this application disclose a path fault detection method and apparatus, a related device, and a storage medium, and belong to the field of communication technologies. In embodiments of this application, a return path is determined according to a forward path. In a path fault detection process, the return path through which a fault detection packet fed back by a tail node to a head node passes includes the forward path. In this way, if the head node receives the fault detection packet fed back by the tail node, it indicates that the forward path is not faulty.

Abstract: A polymer binder with high peel strength is used in a secondary lithium battery. The polymer binder is obtained by a ring-opening reaction of polyvinylene carbonate by a nucleophile. The polyvinylene carbonate accounts for 10-90% of the total mass of the polymer binder while the nucleophile accounts for 10-90% of the total mass of the polymer binder. The polymer binder has high peel strength (0.02-0.6 N/mm) and high decomposition voltages (4.5-6.0 V), and can be used as an electrode material binder in a secondary lithium battery.

Abstract: A polyoxymethylene-based all-solid-state polymer electrolyte prepared by in-situ ring-opening polymerization is used in forming an all-solid-state secondary lithium battery. A trioxymethylene monomer, an additive and lithium salt initiates in-situ ring-opening polymerization on a porous support material through a catalyst to form the all-solid-state polymer electrolyte, which has a thickness of 10 ?m-800 ?m, an ionic conductivity of 4×10?5 S/cm—8×10?3 S/cm at room temperature and an electrochemical window not lower than 4.2 V.

Abstract: A polymer binder with high peel strength is used in a secondary lithium battery. The polymer binder is obtained by a ring-opening reaction of polyvinylene carbonate by a nucleophile. The polyvinylene carbonate accounts for 10-90% of the total mass of the polymer binder while the nucleophile accounts for 10-90% of the total mass of the polymer binder. The polymer binder has high peel strength (0.02-0.6 N/mm) and high decomposition voltages (4.5-6.0 V), and can be used as an electrode material binder in a secondary lithium battery.

Abstract: An example of a biotin-streptavidin cleavage composition includes a formamide reagent and a salt buffer. The formamide reagent is present in the biotin-streptavidin cleavage composition in an amount ranging from about 10% to about 50%, based on a total volume of the biotin-streptavidin cleavage composition. The salt buffer makes up the balance of the biotin-streptavidin cleavage composition. In some examples, the biotin-streptavidin cleavage composition is used to cleave library fragments from a solid support. In other examples, other mechanisms are used to cleave library fragments from a solid support.

Abstract: Some embodiments of the methods and compositions provided herein relate to the preparation and use of nucleic acid libraries derived from RNA and DNA. In some embodiments, a nucleic acid library can be prepared by tagging polynucleotides derived from RNA. Some embodiments include the analysis of sequence data from such libraries.

Abstract: The present disclosure relates to the field of molecular biology and more specifically to methods for capturing, amplifying and sequencing target polynucleotides on a solid surface.

Abstract: The present disclosure relates to the field of molecular biology and more specifically to methods for capturing, amplifying and sequencing target polynucleotides on a solid surface.

Abstract: The present disclosure relates to the field of molecular biology and more specifically to methods for capturing, amplifying and sequencing target polynucleotides on a solid surface.

Abstract: The present disclosure relates to the field of molecular biology and more specifically to methods for capturing, amplifying and sequencing target polynucleotides on a solid surface.

Abstract: Methods of treating diseases of a subject through selective occlusion of blood vessels. The methods include identifying and/or mapping the blood vessels supplying nutrients to the diseased or unwanted tissue, delivering an appropriate dose of an occlusion-forming photosensitizer to the subject, and exciting the photosensitizer with sufficient light irradiation in the vicinity of the blood vessels to cause vessel occlusion. The vessel occlusion cuts off nutrient supply to the diseased or unwanted tissue resulting in cell death of that tissue and any other tissue served by the occluded vessels.

Abstract: This invention provides methods and compositions useful for identifying and diagnosing rare fetal cells in a mixed cell population such as a maternal blood sample. The methods entail the use of specific nucleic acid probes that hybridize to fetal cell associated RNAs to identify the rare fetal cells or antibodies that bind to polypeptides encoded by the fetal cell associated RNAs for fetal cell detection. The cells detected by the methods of the present invention are useful for diagnosing the fetal cells for a genetic trait of interest, such as trisomy 21. Novel methods for simultaneous screening for fetal cells and diagnosing the fetal cells are also provided. Compositions comprising the fetal cell associated nucleic acids of the invention and their encoded proteins are also provided. The present invention further provides kits useful for practicing the present methods.

Abstract: This invention provides methods and compositions useful for identifying and diagnosing rare fetal cells in a mixed cell population such as a maternal blood sample. The methods entail the use of specific nucleic acid probes that hybridize to fetal cell associated RNAs to identify the rare fetal cells or antibodies that bind to polypeptides encoded by the fetal cell associated RNAs for fetal cell detection. The cells detected by the methods of the present invention are useful for diagnosing the fetal cells for a genetic trait of interest, such as trisomy 21. Novel methods for simultaneous screening for fetal cells and diagnosing the fetal cells are also provided. Compositions comprising the fetal cell associated nucleic acids of the invention and their encoded proteins are also provided. The present invention further provides kits useful for practicing the present methods.